• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

OncoScore:一种新的基于互联网的基因致癌潜能评估工具。

OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes.

机构信息

University of Milano-Bicocca, Dept. of Medicine and Surgery, Monza, 20900, Italy.

Stanford University, Dept. of Pathology, California 94305, USA.

出版信息

Sci Rep. 2017 Apr 7;7:46290. doi: 10.1038/srep46290.

DOI:10.1038/srep46290
PMID:28387367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5384236/
Abstract

The complicated, evolving landscape of cancer mutations poses a formidable challenge to identify cancer genes among the large lists of mutations typically generated in NGS experiments. The ability to prioritize these variants is therefore of paramount importance. To address this issue we developed OncoScore, a text-mining tool that ranks genes according to their association with cancer, based on available biomedical literature. Receiver operating characteristic curve and the area under the curve (AUC) metrics on manually curated datasets confirmed the excellent discriminating capability of OncoScore (OncoScore cut-off threshold = 21.09; AUC = 90.3%, 95% CI: 88.1-92.5%), indicating that OncoScore provides useful results in cases where an efficient prioritization of cancer-associated genes is needed.

摘要

癌症突变的复杂、不断变化的情况给在 NGS 实验中通常产生的大量突变列表中识别癌症基因带来了巨大挑战。因此,优先考虑这些变体的能力至关重要。为了解决这个问题,我们开发了 OncoScore,这是一种文本挖掘工具,它根据可用的生物医学文献,根据与癌症的关联对基因进行排名。在手动整理的数据集上进行的接收器操作特性曲线和曲线下面积 (AUC) 指标验证了 OncoScore 的出色区分能力 (OncoScore 截止阈值=21.09;AUC=90.3%,95%CI:88.1-92.5%),表明 OncoScore 在需要有效优先考虑癌症相关基因的情况下提供了有用的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9052/5384236/a39c3e2ba8f8/srep46290-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9052/5384236/eecfb4c3670a/srep46290-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9052/5384236/9ffaefa5b188/srep46290-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9052/5384236/06d9f09c35fa/srep46290-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9052/5384236/a39c3e2ba8f8/srep46290-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9052/5384236/eecfb4c3670a/srep46290-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9052/5384236/9ffaefa5b188/srep46290-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9052/5384236/06d9f09c35fa/srep46290-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9052/5384236/a39c3e2ba8f8/srep46290-f4.jpg

相似文献

1
OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes.OncoScore:一种新的基于互联网的基因致癌潜能评估工具。
Sci Rep. 2017 Apr 7;7:46290. doi: 10.1038/srep46290.
2
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience.基于新一代测序的髓系 panel 在急性髓系白血病中的验证:单中心经验。
Leuk Res. 2022 Jul;118:106861. doi: 10.1016/j.leukres.2022.106861. Epub 2022 May 19.
3
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes.勘误:OncoScore:一种基于互联网的新型工具,用于评估基因的致癌潜力。
Sci Rep. 2017 May 22;7:46823. doi: 10.1038/srep46823.
4
CRAVAT: cancer-related analysis of variants toolkit.CRAVAT:癌症相关变异分析工具包。
Bioinformatics. 2013 Mar 1;29(5):647-8. doi: 10.1093/bioinformatics/btt017. Epub 2013 Jan 16.
5
PubMatrix: a tool for multiplex literature mining.PubMatrix:一种用于多重文献挖掘的工具。
BMC Bioinformatics. 2003 Dec 10;4:61. doi: 10.1186/1471-2105-4-61.
6
CIGene: a literature-based online resource for cancer initiation genes.CIGene:一个基于文献的癌症起始基因在线资源。
BMC Genomics. 2018 Jul 25;19(1):552. doi: 10.1186/s12864-018-4944-y.
7
Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations.体细胞突变的癌症特异性高通量注释:驱动错义突变的计算预测
Cancer Res. 2009 Aug 15;69(16):6660-7. doi: 10.1158/0008-5472.CAN-09-1133. Epub 2009 Aug 4.
8
ContrastRank: a new method for ranking putative cancer driver genes and classification of tumor samples.对比排名:一种用于对假定的癌症驱动基因进行排名和肿瘤样本分类的新方法。
Bioinformatics. 2014 Sep 1;30(17):i572-8. doi: 10.1093/bioinformatics/btu466.
9
DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.DrGaP:一种在癌症测序研究中识别驱动基因和途径的强大工具。
Am J Hum Genet. 2013 Sep 5;93(3):439-51. doi: 10.1016/j.ajhg.2013.07.003. Epub 2013 Aug 15.
10
COSMIC: exploring the world's knowledge of somatic mutations in human cancer.COSMIC:探索全球关于人类癌症体细胞突变的知识。
Nucleic Acids Res. 2015 Jan;43(Database issue):D805-11. doi: 10.1093/nar/gku1075. Epub 2014 Oct 29.

引用本文的文献

1
Integrative analysis of epigenetic and transcriptional interrelations identifies histotype-specific biomarkers in early-stage ovarian carcinoma.表观遗传与转录相互关系的综合分析确定了早期卵巢癌的组织学类型特异性生物标志物。
J Ovarian Res. 2025 May 19;18(1):103. doi: 10.1186/s13048-025-01676-5.
2
Global analysis of actionable genomic alterations in thyroid cancer and precision-based pharmacogenomic strategies.甲状腺癌中可操作基因组改变的全球分析及基于精准医学的药物基因组学策略
Front Pharmacol. 2025 Apr 14;16:1524623. doi: 10.3389/fphar.2025.1524623. eCollection 2025.
3
CancerHubs: a systematic data mining and elaboration approach for identifying novel cancer-related protein interaction hubs.

本文引用的文献

1
Age-related somatic mutations in the cancer genome.癌症基因组中与年龄相关的体细胞突变。
Oncotarget. 2015 Sep 22;6(28):24627-35. doi: 10.18632/oncotarget.5685.
2
MiR200c targets IRS1 and suppresses prostate cancer cell growth.微小RNA-200c靶向胰岛素受体底物1并抑制前列腺癌细胞生长。
Prostate. 2015 Jun;75(8):855-62. doi: 10.1002/pros.22968. Epub 2015 Feb 14.
3
Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data.前列腺癌中复发性拷贝数改变:对公开可用基因组数据的计算机荟萃分析
癌症枢纽:一种用于识别新型癌症相关蛋白质相互作用枢纽的系统数据挖掘与阐释方法。
Brief Bioinform. 2024 Nov 22;26(1). doi: 10.1093/bib/bbae635.
4
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma.FAT 家族钙黏蛋白的反复体细胞突变导致间变大细胞淋巴瘤表现出侵袭性表型和不良预后。
Br J Cancer. 2024 Dec;131(11):1781-1795. doi: 10.1038/s41416-024-02881-7. Epub 2024 Oct 30.
5
Internet-Based Abnormal Chromosomal Diagnosis During Pregnancy Using a Noninvasive Innovative Approach to Detecting Chromosomal Abnormalities in the Fetus: Scoping Review.基于互联网的孕期染色体异常诊断:使用无创创新方法检测胎儿染色体异常的范围综述
JMIR Bioinform Biotechnol. 2024 Oct 16;5:e58439. doi: 10.2196/58439.
6
Systematic prioritization of functional variants and effector genes underlying colorectal cancer risk.系统优先级排序结直肠癌风险相关的功能变体和效应基因。
Nat Genet. 2024 Oct;56(10):2104-2111. doi: 10.1038/s41588-024-01900-w. Epub 2024 Sep 16.
7
New oncogenic functions of LINE1 retroelement as a ceRNA for tumor suppressive microRNA miR-126 on ENPP5.LINE1 反转录元件作为肿瘤抑制 microRNA miR-126 的 ceRNA 对 ENPP5 的新致癌功能。
PLoS One. 2023 Jun 23;18(6):e0286814. doi: 10.1371/journal.pone.0286814. eCollection 2023.
8
Cytotoxic Activity of α-Aminophosphonic Derivatives Coming from the Tandem Kabachnik-Fields Reaction and Acylation.由串联卡巴奇尼克-菲尔德反应和酰化反应得到的α-氨基膦酸衍生物的细胞毒性活性
Pharmaceuticals (Basel). 2023 Mar 28;16(4):506. doi: 10.3390/ph16040506.
9
Pan-cancer analysis of cuproptosis regulation patterns and identification of mTOR-target responder in clear cell renal cell carcinoma.泛癌症分析铜死亡调控模式,并鉴定透明细胞肾细胞癌中 mTOR 靶向反应者。
Biol Direct. 2022 Oct 8;17(1):28. doi: 10.1186/s13062-022-00340-y.
10
Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants.高危神经母细胞瘤的全外显子组测序鉴定出新型非同义变异。
PLoS One. 2022 Aug 29;17(8):e0273280. doi: 10.1371/journal.pone.0273280. eCollection 2022.
Cancer Genet. 2014 Oct-Dec;207(10-12):474-88. doi: 10.1016/j.cancergen.2014.09.003. Epub 2014 Sep 16.
4
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.非典型慢性髓性白血病中反复出现的 ETNK1 突变。
Blood. 2015 Jan 15;125(3):499-503. doi: 10.1182/blood-2014-06-579466. Epub 2014 Oct 24.
5
Characterization of the genomic architecture and mutational spectrum of a small cell prostate carcinoma.小细胞前列腺癌基因组结构与突变特征分析。
Genes (Basel). 2014 May 12;5(2):366-84. doi: 10.3390/genes5020366.
6
Transient induction of ING4 by Myc drives prostate epithelial cell differentiation and its disruption drives prostate tumorigenesis.Myc对ING4的短暂诱导驱动前列腺上皮细胞分化,而其破坏则驱动前列腺肿瘤发生。
Cancer Res. 2014 Jun 15;74(12):3357-68. doi: 10.1158/0008-5472.CAN-13-3076. Epub 2014 Apr 24.
7
Targeting CDC25C, PLK1 and CHEK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancer.靶向细胞周期蛋白依赖性激酶25C(CDC25C)、丝氨酸/苏氨酸蛋白激酶1(PLK1)和细胞周期检测点激酶1(CHEK1)以克服前列腺癌中由LZTS1缺失诱导的多西他赛耐药性。
Oncotarget. 2014 Feb 15;5(3):667-78. doi: 10.18632/oncotarget.1574.
8
Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases.在骨髓增殖性疾病中整合全外显子组和 RNA-seq 数据鉴定剪接位点的新型点突变。
Mol Genet Genomic Med. 2013 Nov;1(4):246-59. doi: 10.1002/mgg3.23. Epub 2013 Jul 7.
9
CEQer: a graphical tool for copy number and allelic imbalance detection from whole-exome sequencing data.CEQer:一种用于从全外显子组测序数据中检测拷贝数和等位基因失衡的图形工具。
PLoS One. 2013 Oct 4;8(10):e74825. doi: 10.1371/journal.pone.0074825. eCollection 2013.
10
Somatic SETBP1 mutations in myeloid malignancies.体细胞 SETBP1 突变与髓系恶性肿瘤。
Nat Genet. 2013 Aug;45(8):942-6. doi: 10.1038/ng.2696. Epub 2013 Jul 7.